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Abstract
Background: To retrospectively compare the operation time, success rate and efficacy between unidirectional and
bidirectional procedures in the treatment of central venous occlusion diseases (CVOD), assess the advantages of
the bidirectional approach, and determine the characteristics of CVOD appropriate for the bidirectional approach
treatment.
Methods: A total of 49 patients who underwent endovascular interventions with all relevant data between
January 2011 and December 2015 at the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China,
were included in this retrospective study, and were categorized into two groups: the 19 patients in group
1 had undergone percutaneous transluminal venoplasty (PTV) via a conventional technique (unidirectional
procedure from the vein distal or proximal to the obstructive lesion), and the 30 in group 2 had undergone
flossing wire technique (bidirectional procedure from femoral vein and the vein distal to obstructive lesion
and using a flossing wire technique). The technical success rate, the fluoroscopy time in the procedure,
perioperative complications, and patency were evaluated retrospectively.
Results: Compared with group 1, group 2 had a higher initial technical success rate (83.33% vs. 47.36%,
p = 0.012) but a shorter fluoroscopy time (82.6 ± 26.1 vs. 116.1 ± 42.1, p = 0.048). Receiver operating characteristic (ROC)
analysis indicated that a lesion with a length of 6.5 cm was the best predictor of technique success (p = 0.02) in group
1, but no cut-off value was identified for group 2. There were no significant differences in perioperative complications
between these two groups. The complication rates were 31.58% (6/19) in group 1 and 6.67% (2/30) in group
2, (p = 0.043), respectively. No significant difference was observed between these two groups with respect to
the stent patency rate.
Conclusion: Compared with the conventional technique, the flossing wire technique has a higher success
rate, shorter fluoroscopy time, fewer complications and similar patency rate. It is a feasible treatment for
CVOD, especially for long obstructive lesions.
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Background
Central venous occlusive disease (CVOD) is a challenge
frequently encountered in the treatment of hemodialysis
[1]. CVOD is often caused by the placement of a central
vein catheter; however, other etiologies have also been
mentioned [1–4]. CVOD often develops rapidly, mani-
festing as increasing massive edema in the ipsilateral
arm or neck, aneurysmal dilation of the fistula, and pro-
longed bleeding times after needle removal, which is
often accompanied by the progressive failure of the
fistula [1]. It is important to conduct a timely and effect-
ive treatment for CVOD with the goal not only of reliev-
ing the patient’s symptoms, but also of maintaining the
function of AVF or AVG.
While the optimal management of CVOD remains
under debate, surgical approaches have been used to
increase the availability of access sites and relieve symp-
toms, and were reported to have a primary patency rate
of 80–90% after one year [5]. However, surgical
approaches require general anesthesia and exhibit a high
rate of surgical morbidity when used in cases with end-
stage renal disease. As an alternative to surgical treat-
ments, endovascular interventions have been performed
for over 10 years and have obtained appreciable success
rates and benefits, although repeated interventions have
still been required in certain cases [6–8].
At present, there is no generally accepted guideline for
CVOD intervention. The traditional intervention tech-
nique is typically a single-direction (unidirectional)
single approach (single access) technique, which may
achieve a higher success rate for vein stenosis or short
occluded lesions. The flossing wire technique (or the
through-and-through wire technique) has occasionally
been reported in the literature, but its clinical applica-
tion was only limited to complex cases. The sample size
in all prior published studies was limited, and no study
has explored the advantages of this technique or what
time is appropriate for employing this technique on
patients. On the other hand, different studies reported
various success rates, as various medical centers had
different levels of technical control and treated patients
with various severity of CVOD [1, 6, 9–14].
The current study was conducted to retrospectively
evaluate the clinical feasibility of using a flossing wire
for treating complete CVOD based on 5 years of data
stored in our center, and was intended to identify major
factors which had limited the success rate of endovascu-
lar treatment and discuss the potential value of flossing
technique in dialysis patients with special conditions.
Methods
Cases
From January 2011 to December 2015, 89 CVOD
patients with hemodialysis fistula had been referred to
our medical center for venographic analysis and endo-
vascular treatment due to arm or neck swelling or ele-
vated venous pressure of fistula outflow. Forty-nine
cases with full relevant information for this study were
enrolled (28 males and 21 females; mean age 56.5 years,
age range 29–81 years). The protocol of this study was
approved by the ethics committee of the First Affiliated
Hospital of Sun Yat-Sen University. The study was
conducted in accordance with the Declaration of
Helsinki and other international guidelines. Informed
consent from individual participant was waived by the
committee due to the retrospective nature of this
study. All medical records were reviewed retrospect-
ively, and the details of each intervention were ob-
tained by reviewing radiologic reports and venograms.
All enrolled cases, presented with location, type, and
degree of central venous occlusion, were confirmed
by computed tomography, ultrasound, and venog-
raphy. The standards and definitions used in this
study were described in detail below with the refer-
ence of the National Kidney Foundation-Dialysis Out-
comes and Quality Initiative (NKF-DOQI). The
patients’ demographics, risk factors and indications
for intervention are displayed in Table 1.
Table 1 Comparison of demographics, risk factors and
indications for intervention in patients between single and
dual access groups
Demographics No, (%) or Mean ± SD (range)
Group 1 Group 2 p Value
Number of patients (n) 19 30
Age, years 57.03 ± 10.9 55.68 ± 11.69 0.684
Sex
Male, n 12 16 0.773
Female, n 6 14
Diabetics
Diabetic, n (%) 8(42%) 16(53%) 0.561
Non-diabetic, n (%) 11(58%) 14(47%)
Duration of symptom (M) 4.4 ± 1.98 5.1 ± 1.81 0.213
Duration of dialysis (M) 55.6 ± 11.69 57.0 ± 10.92 0.689
Age of fistula (M) 14.6 ± 7.57 19.7 ± 10.26 0.056
Type of fistula
AVF, n (%) 6 (32%) 16 (53%) 0.155
AVG, n (%) 13 (68%) 14 (47%)
History of CVC 17 (89%) 29 (97%) 0.551
Indication for intervention
Swelling, n (%) 17 (89%) 30 (100%) 0.145
High venous pressure, n (%) 14 (73%) 25 (83%) 0.480
Clotted access, n (%) 3 (15%) 3 (10%) 0.665
Non-specified, n (%) 1 (5%) 0 (0%) 0.388
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Standards and definitions
Definition of patency rate
Patency rates were defined according to the Committee
on Reporting Standards for Arterio-Venous Accesses of
the Society for Vascular Surgery and the American Asso-
ciation for Vascular Surgery. Patency rate was defined as
a patent interval without recurrent stenosis or the need
for further intervention after device implantation.
Definition of technical success
Technical success was defined as a complete whole pri-
mary procedure of PTA and deployment of stent, with
no evidence of early failure. Early failure was defined as
an inability to cross the lesion at the time of the primary
procedure, by the presence of an occlusion, or ≥50%
restenosis within the first 30 days after the initial
procedure.
Definition of lesion length
Lesion length was defined as the distance from the def-
inite proximal to the distal shoulder of the lesion in the
projection that best elongated the occlusion. Regardless
of which method was used,simultaneous proximal and
distal angiogram of all lesions were performed as the
first step in the endovascular treatment, and only a por-




All procedures in this study were performed by the same
medical team. Diagnostic digital subtraction venography
from the outflow vein of the fistulas to the right atrium
was achieved by ultrasound-guided percutaneous punc-
ture of fistulas using an 18G trocar and power contrast
injection in all patients. No peripheral venous outflow
occlusions were identified in these patients outside of
the central venous occlusions. After primary identifica-
tion of the distal end of the central vein occlusion lesion,
a second percutaneous puncture access in the femoral
vein was set up with a 4 F micropuncture kit (Terumo),
followed by the insertion of a 4 F multipurpose angled
(MPA) catheter (Cordis) to the proximal end of the oc-
clusion lesion. Further venography by synchronous
power contrast injection from both ends of the lesion
with high magnification in multiple projections was per-
formed again to identify the length and position of the
occluded segment, and to determine the diameter of the
normal vein close to the lesion.
Conventional technique procedure
In patients of group 1, main endovascular intervention
was performed via one access regardless of the number
and site of the punctures that had been performed dur-
ing the full procedure. In this group, three different ac-
cesses were adopted to introduce the recanalization
devices: 1) installing a femoral vein access as the main
recanalization approach (Fig. 1); 2) fistula access: a 4 F
Terumo sheath was inserted through the first puncture
access of fistula described above; 3) generating a new
intervention access with a 4 F Terumo puncture kit in
the upper arm or the clavicular region, guided by ultra-
sound or venography in a position about 7–10 cm distal
distance from the occlusion lesion, and we always called
this access as “the third way” (Fig. 2). The criteria for the
selection of the optimal access approach were based on
the lesion characteristics. We always preferred choosing
the femoral vein access or the fistula access first. How-
ever, if the lesion could not be crossed successfully, “the
third way” must be considered (Fig. 3). After interven-
tion access was installed, two technical phases, crossing
the occlusion and recanalization, were performed as
followed. In the first phase, a 4Fr 65-cm-long MPA cath-
eter (Cordis) with a 0.035-in., 3-mm J tip, 135-cm-long
Fig. 1 Single venous access approach through femoral vein. This case had an occluded short segment on left innominate vein. a. Angiography showed a
3 cm occluded segment, and catheter was advanced directly through the occluded point to the distal end via femoral vein. b. Stent was released on the
occluded segment and balloon was dilated. c. After successful stent placement, angiography showed complete restoration of blood flow
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hydrophilic Glide wire (Terumo) was inserted to cross
the occlusion lesion, followed by the change of the wire
from a hydrophilic Glide wire (Terumo) wire to a 260-cm
length, 0.035-in. Super Stiff Amplatz (Meditech/Boston
Scientific) or Super Stiff hydrophilic wire (Terumo). Out
of all 19 patients, the procedure was successfully per-
formed in 15, including 7 patients with fistula access, 3 pa-
tients with outflow venous access, and 5 patients with
femoral vein access. Four patients had a failed pro-
cedure and eventually required a surgical solution.
The next phase-recanalization was continued after 1ST
phase have been completed. The venous access
sheath(s) in the successful 15 cases was then ex-
changed for an 8 F, 5-cm-long Terumo sheath,
followed by a stepwise pre-dilation procedure. Briefly,
a number of high-pressure balloons (with diameters
ranging from 6 mm to 12 mm, step by step) was
used to dilate the central vein occlusion. In 7 pa-
tients, the dilate balloon was pushed smoothly
through the lesion. In other 8 patients, the balloon
did not cross the central vein occlusion with the
above mentioned approach. In these 8 cases, the
sheath of intervention access site was exchanged for a
5 F, 30-cm-long Abrahams sheath with an angled tip
(Cook), with the tip of this sheath being placed as
close to the occlusion as possible. In 2 of these 8 pa-
tients, the balloon was finally pushed through the le-
sion site successfully. Among the remaining 6
patients, 3 required the use of the flossing wire tech-
nique, but these were not included in group 2 to
avoid data duplication, and the remaining 3 had sur-
gical interventions. Prior to stent deployment, the
length of the stent was determined based on the
length of the lesion, which was obtained from exten-
sive power-injector central venous system venography.
All patients received one or two stents when there
was a central venous occlusion with suboptimal PTA,
despite complete effacement of the lesion after PTA.
Fig. 3 Recanalization of the distal occlusion. This case had an occluded segment on the right innominate vein. a Direct puncture followed by the
insertion of a 6Fr sheath was performed on the distal occluded segment, and angiography showed the occlusion of the distal end. b Femoral
vein angiography showed the occlusion of the proximal end. c Stent was successfully inserted after guide wire was advanced through distal end of
occluded segment. d Angiography showed complete restoration of blood flow thorough previously occluded segment
Fig. 2 Site map of central venous occlusion disease (CVOD). Positions
in red represent places of high incidence of CVOD; positions in gray
are the ones frequently selected as venous access sites (“the third
way”). RIV, right innominate vein; LIV, left innominate vein; LSCV, left
subclavian vein; RSCV, right subclavian vein; SVC, superior vena cava;
EJV, external jugular vein; IJV, internal jugular vein; CAV, cephalicarch
vessel; AXV, axillary vein
Huang et al. BMC Cardiovascular Disorders  (2016) 16:250 Page 4 of 11
Flossing wire technique procedure
In this group, the femoral vein was defined as the
main access to introduce the balloon and stents, but
we also set up another access to introduce the working
guidewire and perform the crossing step mentioned in
the following part; this access was selected between
the two remaining access points mentioned in conven-
tional technique. The dual-access bidirectional floss-
ing wire technique still needed the two procedure
phases used in the conventional technique - crossing
the occlusion and recanalization, but the difference lay
in that the occlusion was crossed via distal access, and
that the stent was placed via the femoral access. The
first step was basically similar to the one mentioned
above. After the catheter and guide wire crossed the
lesion from distal to proximal, a loop snare created by
a 0.18-in. guide wire (Cook) and an 8–10 Fr sheath
(Terumo), and the loop was placed in the junction be-
tween inferior vena cava and femoral vein. Thereafter,
with the assistance of an MPA catheter, a hydrophilic
Glide wire was inserted into the femoral vein to meet
the loop, and a sufficiently long segment was pulled
out of the femoral sheath in preparation for the fol-
lowing interventions, and a short segment of the other
end of the wire was retained and stretched out of the
access to the fistula. Thus, a through-and-through cir-
cuit was set up. Out of the 30 patients of group 2, this
procedure was unsuccessful in 7. Therefore, a new
intervention access with a 4 F or 5 F Terumo puncture
kit in an upper arm or clavicular region in a position
about 7 cm distal to the occlusion lesion was installed,
as mentioned in single technique section, and a trocar
needle kit for PBD with angled metallic cannula
(Cook) was selected for sharp recanalization. The hard
end of a 0.018 guide wire was used as a puncture nee-
dle. Once the wire crossed the lesion, a snare was ex-
changed for the balloon and used to capture the wire.
By stretching the wire, the metallic cannula was ex-
changed with a 4 F MPA catheter (Cordis), and pushed
through the lesion, followed by an exchange for a
0.035-in. Super Stiff 300-cm-long hydrophilic Glide
wire (Terumo), which was captured by the snare and
pulled out of the sheath of femoral. This procedure
was completed successfully in 2 of the 7 patients. The
remaining 5 patients turned to surgical solutions.
After the through-and-through circuit had been set
up, a 10–12-mm-diameter, 80-mm-length balloon was
introduced through the femoral sheath into the occlu-
sion directly, and was dilated in the lesion for 2–3
min. A small balloon with a fine shape was not required
for pre-dilation in this procedure (Figs. 4 and 5). This step
was completed successfully in all 25 patients whose
through-and-through circuit had been installed, and stent
deployment followed.
Stent selection
Each CVOD patient received at least one self-
expandable stent following the venoplasty procedure.
The length of each stent was 10–20 mm longer than the
lesion, and its diameter was 10%–20% larger than that of
the adjacent non-affected vein. The deployed stents had
a mean length of 73.9 mm (range 60–80 mm), and a
mean diameter of 10.6 mm (range 8–14 mm). The
placed stents included four Wallstents (Boston Scientific;
Boston, MA, USA), eighteen Protégé stents (ev3 Inc.;
Plymouth, MA, USA), nine Sinus stents (Optimed;
Germany), seven Zilver stents (Cook Medical; Blooming-
ton, IN, USA), and nine Viabahn (W.L. Gore & Associ-
ates INC; Arizona, U.S.A). Some patients were treated
by two or three stents. No significant difference was
observed with regard to the different stents used in these
two groups (p = 0.35).
Statistical analysis
All statistical analyses were performed using IBM SPSS
Statistics for Windows, Version 19.0 (IBM Corp.;
Armonk, NY) and the results were reported as the mean
± standard deviation (SD). Fisher’s exact test was used to
compare patient demography and the locations of the
lesions. The ROC curve was used to define the cut-off
value of the lesion length affecting the technique suc-
cess. Bivariate analysis was performed by the Chi-square
test, and multiple analysis was performed by Cox regres-
sion. A p value < 0.05 was considered statistically signifi-
cant. Hemodialysis access and stent patency rates were
calculated using Kaplan–Meier analysis.
Results
Patient population
Nineteen patients (group 1) with CVOD underwent sin-
gle vein access PTV, while 30 (group 2) underwent PTV
performed using the flossing wire technique. The partici-
pants of the two groups showed no significant differ-
ences in terms of demographics or the characteristics of
the length of the occlusive lesions (Tables 1 and 2).
Success rate
An initial single femoral venous access PTV procedure
was successfully performed in 9/19 cases (47.36%), and a
through-and-through PTV technique was performed in
25/30 patients (83.33%). The overall PTV success rate in
the flossing wire group was significantly higher than that
in the unidirectional technique group (p = 0.012), although
the success rate of the two groups showed no significant
differences in special locations of lesions, such as in RIV +
SVC, RSCV + RIV, and RSCV + RIV + SVC, probably due
to the limited sample size for each category (Table 3).
Our ROC analysis identified lesion length as a risk
factor for the technical success in the single-access
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venoplasty group. The cut-off value for the lesion
length was 6.5 cm, as calculated using the Youden
Index (Fig. 6a 1, 2). However, there was no signifi-
cant correlation of the lesion length with the
technical success rate of the dual access venoplasty
(Fig. 6b 1, 2).
Fluoroscopy time
Among the patients who were treated successfully
with either single or dual access, the fluoroscopy time
of the whole procedure was significantly different be-
tween those in group 1 and 2 (116.1 ± 42.1 vs. 82.6 ±
26.1 min, respectively, p = 0.048) (Table 5). We further
divided the whole procedure into two steps, the wire
crossing the lesion and PTAS. It showed that the dif-
ference of wire cross was not significant between these
two groups (55.6 ± 15.9 vs. 59.8 ± 21.3 min, respect-
ively, p = 0.540), but the difference in the time spent
in performing PTA and stent deployment was signifi-
cant (60.6 ± 39.95 vs. 22.8 ± 8.5 min, respectively, p =
0.022) (Table 4).
Post operation complications
Complications related to the operations were followed
and recorded within 1 month after the operation in all
patients who had undergone endovascular treatment
Fig. 4 Dual venous access approach for a short occluded segment. The case had an occluded right innominate vein. a Preoperative evaluation of the
length and extent of the occlusion by CT. b Synchronized angiography of the bilateral occluded ends further confirmed the length of occluded segment.
c Guide wire was advanced via distal end of occluded segment. d Loop was pulled out from femoral vein sheath. e Balloon was dilated on the occluded
segment. f Angiography showed successful recanalization after stent release
Fig. 5 Dual venous access approach for a long occluded segment. This case had occluded segment from right subclavian vein to right
innominate vein. a Synchronized angiography of bilateral occluded ends showed occlusion length and site. b Blunt recanalization from both
ends of the occluded segment was performed. c Guide wire was advanced via distal end of occluded segment and crossed occluded segment.
d. Balloon pre-dilation was performed segment by segment. e Angiography showed successful recanalization after placement of two stents
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(regardless success or not). The incidence rate was
31.58% (6/19) in group 1 and 6.67% (2/30) in group 2
(p = 0.043), respectively, suggesting that the dual ac-
cess approach significantly reduced complications
compared with the signal access approach. The com-
plications in group 1 were hematoma at puncture
position (2 patients), thrombus and dysfunction of
access (2 patients), and acute heart failure (1 patient).
The complications in group 2 were acute pericardial
effusion (1 patient) and acute heart failure (1 patient).
Patency rate
The mean follow-up time was 13.85 months. There were
no significant differences between these two groups with
respect to stent patency rate (Table 5).
Discussion
CVOD is the most common major problem encountered
in vascular access [6–8]. Without a timely and effective
management, CVOD usually results in a decrease in lon-
gevity and quality of life in patients.
Currently, endovascular therapy is the preferred
method for treating CVOD, because surgical options are
associated with significant morbidity and are used as
alternative treatments only for patients refractory to per-
cutaneous endovascular treatment. However, reported
technical success rates, complications, and long-term
outcomes of endovascular therapy varied greatly [1, 6,
9–14], which can be attributed to differences in recana-
lizing technique, study methodologies, patient demog-
raphy, and certain characteristics of obstructive lesions
including size and elasticity, as well as the degree of
obstruction [1–4, 11, 15]. According to reports, technical
success rates have been shown to have a range from 70%
to 100% [1, 16]. However, we noted that clinical practice
guidelines, such as the Kidney Disease Outcomes Qual-
ity Initiative (KDOQI) and the European Best Practice
Guidelines (EBPG), were developed in 2002–2006 in
developed countries [17, 18]. Therefore, in these coun-
tries, CVOD can be diagnosed and treated timely. Al-
though not all CVS need to be addressed, because some
studies suggest that there is no close correlation between
CVS-induced abnormal hemodynamic changes and clin-
ical symptoms and only 33% of CVS patients manifest
clinically, [19]. There is no controversy about the neces-
sity of complete occlusion of central vein (CVOD) with
symptoms.
In China, there are currently no general guidelines for
the monitoring of hemodialysis patients. Therefore,
COVD is rarely diagnosed until patients are unable to
receive hemodialysis via vascular access or have severe
upper limb edema that significantly affects daily life,
which led to a situation in which most CVS patients had
progressed to completely occlusion. It makes us available
to screen the enough patients with complete vascular
occlusion rigidly [20, 21]. Different from most of previ-
ous studies in which CVOD was defined as >50% sten-
osis and/or actually included some CVS patients, our
definition of CVOD was strictly defined as complete vas-
cular occlusion, where the original blood flow of outflow
vein is completely blocked before treatment [22].
Endovascular treatment of CVOD or CVS has been
previously reported, but the factors limiting technical
success received little attention [6–14]. Our study
analyzed the technical aspects in the cases of technical
Table 2 Comparison of characteristics of occluded lesions of
patients between single and dual access groups
Group 1 Group 2 p value
Lesion length 6.89 ± 3.69 7.87 ± 3.20 0.259
Lesion location RIV 1 2 0.987
RSCV 0 2
SVC 1 3
IJV+ SVC 1 0
RIV + SVC 3 4
RSCV + RIV 2 3
RSCV + RIV + SVC 2 3
LIV 2 3
LSCV 1 2
LIV + SVC 2 3
LSCV + LIV 3 3
LSCV + LIV + SVC 1 2
RIV right innominate vein; LIV left innominate vein; LSCV left subclavian vein;
RSCV right subclavian vein; SVC superior vena cava; EJV external jugular vein;
IJV internal jugular vein; CAV
Table 3 Dual access group had a higher success rate than the
unidirectional technique group
Locations of lesion Group 1 Group 2 p value
RIV (1/1) 100.00% (2/2) 100.00% -
RSCV (0/0) 0.00% (2/2) 100.00% -
SVC (1/1) 100.00% (3/3) 100.00% -
IJV+ SVC (1/1) 100.00% (0/1) 0.00% -
RIV + SVC (0/2) 0.00% (3/4) 75.00% 0.350
RSCV + RIV (0/2) 0.00% (2/3) 66.67% 0.361
RSCV + RIV + SVC (1/2) 50.00% (2/3) 66.67% 0.709
LIV (1/2) 50.00% (2/2) 100.00% 0.171
LSCV (1/1) 100.00% (2/2) 100.00% -
LIV + SVC (1/2) 50.00% (3/3) 100.00% 0.171
LSCV + LIV (2/3) 66.67% (2/3) 66.67% -
LSCV + LIV + SVC (0/1) 0.00% (1/2) 50.00% -
Total (9/19) 47.36% (25/30) 83.33% 0.012
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failure and found two major aspects accounting for tech-
nical success. These two aspects were “crossing” and
“revascularization.” Crossing is to pass the guidewire
through the occlusion, and revascularization is to pos-
ition the balloon and stent and angioplasty on the
occluded site. “Crossing” has been recognized as key for
technical success as previous reports. The difficulty of
crossing the wire is related to certain characteristics of
obstructive lesions including size and elasticity. There
are three methods to tackle this issue: blunt crossing,
sharp crossing, and balloon puncture crossing [10–13,
23, 24]. As long as the guidewire crosses the occlusion,
the channel for recanalization is established, and the
second step will follow. There are many ways for the
balloon and stent to advance through the occlusion,
including the replacement of super stiff guidewire, use of
a long sheath, and flossing wire techniques. The
Fig. 6 Receiver-operating characteristic (ROC) curves for determination of cutoff value of lesion length and comparison of the success rate between
signal access and dual access groups. A1. In group 1 (unidirectional technique group), the cut-off value of lesion length was predicted to be 6.5 cm,
with 70% sensitivity and 78% specificity, respectively. A2. Chi-square test showed a significant difference of success rate between the length of lesion
which was shorter and longer than cutoff value of 6.5 cm in group 1. B1. In group 2 (dual access group), lesion length had no significant influence on
technique success rate. B2. Technical success rate was not significantly linked to the length of lesion in group 2. AUC, area under ROC curve
Table 4 Dual access group had a shorter fluoroscopy time than
unidirectional technique group during intervention procedure
Group N Mean SD p value
Tcrossing 1 9 55.5556 15.8989 0.540
2 25 59.8000 21.2858
Trevascularization 1 9 60.5556 39.9566 0.022
2 25 22.8000 8.54888
Twhole 1 9 116.1111 42.1143
2 25 82.6000 26.0656 0.048
Tcrossing: amount of time spent in crossing the wire; Trevascularization:
amount of time spent in revascularization; Twhole: total amount of time spent
in completing the entire procedure
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occlusion length, extent and location are main factors
influencing the resistance to passing the balloon through
the occlusion. Our study showed that this second step of
the operation was also the key to the success of the
intervention. For instance, in all 34 successful cases in
two groups, the entire average fluoroscopy time was
101 min, of which the first step took an average of
57 min, and the second step took an average of 41 min,
accounting for 56% and 40% of the entire operation
time, respectively. Second, in 9 of 15 cases of treatment
failure, the first step was not completed, and 6 cases did
not pass the second step, accounting for 60% and 40% of
the total failure number, respectively. Thus, the second
step contributed significantly to the overall operation
time and the failure rate. In addition, based on the litera-
ture and our study, during the wire-crossing process, the
actual use of a sharp crossing or balloon puncture tech-
nique was not frequent in successful cases. In 40 cases
with successful crossing the wire (i.e., the first step), 2
cases had a sharp crossing technique. However, in 9
cases which failed, 1 used a sharp crossing. In 14 suc-
cessful cases reported by Kundu et al., only 1 case used
a sharp needle [25]. Therefore, we believe that using a
sharp crossing technique had no significant impact on
the overall success rate, because it was not frequently
needed in the cases reported. In contrast, in the second
step, a single approach super-stiff guidewire replacement
and long sheath support assistive technologies were used
for some of our patients, and a flossing wire technique
was used for some others. Only the latter obtained a
100% success rate, suggesting that the flossing wire tech-
nique is the most effective measure to solve difficulties
encountered during the second step. In addition,
although some patients showed failure in the first tech-
nique and were successfully switched to the second,
these patients were not included in this study to avoid
interference by data duplication.
The flossing wire technique was reported to treat cen-
tral venous occlusion in 1996, and has been consistently
used since then [26–30]. In previous reports, the flossing
wire technique was not listed as an individual technique
but was used in handling complicated cases, as reported
by Kundu and Haage [25, 31]. In our study, this tech-
nique was used for 30 patients, and we obtained and
analyzed more data related to the use of this technique.
Our findings suggest that flossing wire technology
significantly reduced fluoroscopy time, and obtained a
high success rate and low complication rates.
Our findings suggest that the use of the flossing wire
technique can increase the surgical success rate through
a better approach to handle the issue of balloon crossing
the occlusion, which may be attributable to the following
aspects: first, it solves the issue occurring when a wire
guiding balloon through the occlusion meets resistance,
rolls back, and is twisted. The length of the occluded
segment is considered as the primary factor affecting the
technical success rate; it affects both guidewire crossing
the occlusion and balloon catheter crossing stenosis
[32]. However, for the time being, no unified length-
measurement method has been adopted. We used a
synchronous bilateral fluorescein imaging technique to
determine the length of the occluded segment, which
fully presented the original information of the occluded
segment prior to intervention. Our studies have shown
that 6.5 cm is a critical length of occluded segment for a
unidirectional technique approach. If the occlusion is
longer than 6.5 cm, treatment success rate will be
significantly compromised, because the long occluded
segment increases the resistance to a certain level, such
that the forced advance of the guidewire and balloon
catheter will be rolled back and twisted. In our unidirec-
tional technique group, 8 cases of failure had a length of
occlusion longer than 6.5 cm, of which 4 cases failed
during second step. Some studies used long sheaths to
increase the chance of success [10, 25] as we did in our
study. However, we did not succeed with this approach
in patients with a large lumen diameter of blood vessel
localized before and after the occluded segment. In
addition, when the occlusion occurs at the turning point,
direction change is the factor that resists the advance of
balloon catheter, because a long sheath only increases
propulsion but does not provide steering force. Flossing
guidewire technology has the advantage of offering suffi-
cient propulsion and steering force, which is the major
reason why endovascular treatment has been widely
used in recent years. For example, the flossing guidewire
technique is efficient and useful to guide the stent
through the places of extreme bending, such as the aor-
tic arch in aortic dissection, usually referred to as the
"Gothic arch" [3, 33–35]. The “Gothic arch” also exists
in the central venous structures. To pass a balloon
through the "Gothic arch" occlusion without the guiding
Table 5 Dual access group had higher patency rates of hemodialysis access than the unidirectional technique group
Patency Time Primary patency rates (%) Secondary patency rates (%)
Group 1 Group2 P Value Group 1 Group2 P Value
Stent 6 m 76.92% 90.48% 0.348 100% 95.24% 1.00
12 m 50.00% 53.85% 1.000 75.00% 84.61% 0.618
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force provided by the stretching guidewire is difficult,
and it will also be difficult for those stents with poor
compliance, the latter of which may steer away from the
original direction and may hence pierce the wall of the
blood vessel. Our preliminary data showed that for the
lesions in certain places, such as the right innominate
vein, the cross-left innominate vein, or the superior vena
cava, using through-and-through technology tended to
achieve a higher success rate.
In addition, the data from the follow-up with the
patients with successful operations in these two groups
showed no significant differences in the primary patency
rates (%) and secondary patency rates (%). Thus, from
the technical point of view, the improved flossing guide-
wire technique did not affect the long-term therapeutic
effects of the patients who had been treated successfully.
However, the flossing wire technique has advantages
with regards to short-term complications. The unidirec-
tional technique approach has two options, from either
the proximal or the distal end of the occluded segment.
For the occlusion of the long segment, performing re-
canalization from the distal end is preferred because the
distance is shorter and the operation is more control-
lable [10, 14]. This approach usually takes a shunt or
draining vein as a channel for the import of various inter-
ventional devices, and requires a catheter sheath with a
size of 8Fr or even larger, which has a high risk of generat-
ing hematoma [36]. Although the pressure of the shunt
and outflow vein differs in AVF and AVG. The effective
ΔP in the fistula generally is only 8 to10 mm Hg, fre-
quently 25%, and seldom more than half those noted in
grafts [17]. Given that many patients with kidney diseases
have hypertension, hemostasis should be implemented
timely and efficiently and should be given sufficient
amount of time after the sheath pullout. Under the impact
of extreme edema of the lesion, hemostasis performed ac-
tually will not be the same as that achieved by artery
pressing. Vascular closure devices may reduce the inci-
dence of hematoma, but may also theoretically increase
the risk of draining vein stenosis [9]. In our flossing wire
approach, we introduced catheter and wire through the
distal access with a 4Fr vascular sheath, which significantly
reduced the damage to the vascular access. We usually
chose the femoral vein as another access with an 8fr or
even larger vascular sheath to the balloon and stent. Fem-
oral vein access is generally recognized as a safe passage,
and the use of a large sheath has no impact on dialysis.
Therefore, we did not see complications such as
hematoma and dialysis access occlusion, as observed in
the unidirectional technique procedure.
In the present study, we also found that the flossing
wire technique had shorter fluoroscopy time than the
unidirectional technique approach during the full treat-
ment period, although it was required to generate two
vascular access sites, because the guidewire stretching
saved time during the second step. Using the flossing
guidewire technique, the stent was managed to cross the
occlusion and deployed directly. By contrast, using the
unidirectional technique approach, in order to ensure
that the stent crosses the occlusion and is positioned
smoothly, a small balloon is usually needed for pre-
dilation. Therefore, in the second part of the procedure,
the flossing guidewire technique is actually succinct.
Conclusions
There were no significant differences in the patency rate
between these two approaches in our study. Previous
studies showed that the nature of the lesion and the
stent type (bare stent or stent graft) will affect the
patency rate, but did not investigate the impact of tech-
niques used on the patency rate. In the present study,
we did not see the difference in the number of specific
stenting types used in the patients of these two groups,
and the comparable patency rate between these two
groups suggested that the technique was not a major
determinant for the patency. Therefore, we concluded
that flossing wire technology is a simpler and safer treat-
ment for CVOD, especially for the long segment occlu-
sion. However, our study was a retrospective study with
a limited sample size. Given that the success rate and
patency rate are affected by multiple factors including
lesion characteristics, stenting type, and patient’s compli-
ance, our findings need to be further corroborated in the
future studies with a large sample size and more data
through multivariate analysis [2, 37].
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